CVE-2024-41668
cBioPortal Proxy Endpoint Vulnerabliity
The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable /proxy endpoint entirely via, for example, nginx.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- Low
- Integrity
- Low
- Availability
- Low
Exploit likelihood
What each source reports
CVE List Score used
cBioPortal Proxy Endpoint Vulnerabliity
The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable /proxy endpoint entirely via, for example, nginx.
- Record
CVE-2024-41668- CVSS 3.1
- 8.3 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L - Weakness
- CWE-918
- Updated
- 2026-11-02
EUVDEUVD-2024-39122
The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable /proxy endpoint entirely via, for example, nginx.
- Record
EUVD-2024-39122- CVSS 3.1
- 8.3 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L - Updated
- 2026-11-03
NVD
The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable /proxy endpoint entirely via, for example, nginx.
- Record
CVE-2024-41668- CVSS 3.1
- 8.3 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L - Weakness
- CWE-918
- Updated
- 2026-11-02
OSV
cBioPortal Proxy Endpoint Vulnerabliity
The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable /proxy endpoint entirely via, for example, nginx.
- Record
CVE-2024-41668- CVSS 3.1
- 8.3 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L - Weakness
- CWE-918
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases, published | EUVD | |
| first indexed | CVE List, NVD, OSV |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2024-41668 is a high vulnerability (CVSS 8.3) in Cbioportal, published July 23, 2024. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.58%, the 47th percentile. No source names a fixed version.
References
github.com/cBioPortal/cbioportal/security/advisories/GHSA-9h44-r3c3-q7rm
wizlynxgroup.com/security-research-advisories/vuln/WLX-2024-004
nvd.nist.gov/vuln/detail/CVE-2024-41668